Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05509712 · ClinicalTrials.gov registry record
Physical Activity Smartphone App for African American Men (FitBros) Phase I
A clinical trial, sponsored by Klein Buendel.
- Completed
- Registry status
- 38
- Enrollment target
NCT05509712: Completed study, sponsored by Klein Buendel.
NCT05509712 is a clinical trial that has completed, run by Klein Buendel. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05509712 has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Low physical activity levels contribute to African American men experiencing health disparities across a number of chronic diseases. Studies have been effective in increasing physical activity levels in African American men; but few have targeted maintenance of behavior change and none have utilized emerging technologies. The purpose of the current study is to further develop a mobile phone application for African American men that will help them initiate and maintain their physical activity levels.
Primary Outcome
Notes from focus group members include perceptions, ease of use, and interest in the app design/features and identified additional or unnecessary features for adopting and maintaining physical activity (PA). Notes are consolidated and utilized for qualitative analysis via a thematic analytic approach.
Interventions
- BEHAVIORAL Focus Groups to Refine MobileMen App Content
- BEHAVIORAL Beta testing of MobileMen App Prototype
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-03-07 |
| Est. Completion | 2022-07-31 |
What the finished NCT05509712 record still lists
NCT05509712 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Focus Groups to Refine MobileMen App Content is the first listed.
NCT05509712 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05509712 about?
NCT05509712 is a clinical study titled "Physical Activity Smartphone App for African American Men (FitBros) Phase I". Low physical activity levels contribute to African American men experiencing health disparities across a number of chronic diseases. Studies have been effective in increasing physical activity levels in African American men; but few have targeted maintenance of behavior change and none have utilized...
What is the current status of trial NCT05509712?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2022-03-07. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT05509712?
The interventions under investigation include: Focus Groups to Refine MobileMen App Content (BEHAVIORAL), Beta testing of MobileMen App Prototype (BEHAVIORAL).
Who is sponsoring clinical trial NCT05509712?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI